Request Deal Involvement

Bora Pharmaceuticals to acquire Baltimore-Camden manufacturing site from Emergent BioSolutions, for $30m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Covington & Burling

legal advisors

Covington & Burling

Truist Securities

financial advisors

Truist Securities

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

or

Principals

EMERGENT BIOSOLUTIONS (BALTIMORE-CAMDEN MANUFACTURING SITE)

target

EMERGENT BIOSOLUTIONS (BALTIMORE-CAMDEN MANUFACTURING SITE)

EMERGENT BIOSOLUTIONS INC

vendor

EMERGENT BIOSOLUTIONS INC

BORA PHARMACEUTICALS CO

bidder

BORA PHARMACEUTICALS CO

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite